Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Expert Interviews
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Service / Activity
Reset
1 / 7
1 / 7
CRDO
Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development
Silvia Steyrer-Gruber
Coriolis Pharma
PAO-07-24-CL-05
July 16, 2024
Women's Health
Revolutionizing Biologics (and Biology) through a Focus on Women
Chia Chia Sun; Gardiner Smith
Fab Biopharma
PAO-07-24-CL-03
July 09, 2024
Hybrid Modeling
Accelerating and Improving Bioprocess Development with Machine Learning Solutions
Michael Sokolov, Ph.D.; Alessandro Butté, Ph.D.
DataHow
PAO-06-24-CL-04
June 18, 2024
Pharmacovigilance
Navigating Shifting Requirements and an Explosion of Data in Pharmacovigilance
Sally Amanuel
PrimeVigilance
PAO-06-24-CL-10
June 05, 2024
Neurology
The Next Frontier in Neurological Diagnostics and Therapeutics
Dave Rosa
NeuroOne
PAO-05-24-CL-02
May 30, 2024
Clinical Trials
Optimizing Oncology and Rare Disease Clinical Trials by Focusing on Science and Aligning with both Patients and Investigators
Dave Selkirk
Ergomed
PAO-06-24-CL-09
May 30, 2024
IND, NDA, and BLA
Building a Regulatory Roadmap for IND, NDA, and BLA
Rebecca Lamb-Wharton, Ph.D.; Brenda Schlenk, RPh; Mamadou Diallo, PharmD
PAO-03-24-CL-10
March 26, 2024
mRNA–LNP Manufacturing
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
Antonio Costa, Ph.D.; William Pasek
DIANT Pharma
PAO-03-24-CL-08
March 18, 2024
Viral Vectors
A Viral Vector CDMO Vision that Resonates
Drew Brennan; Chris Berger; Elie Hanania, Ph.D.; Dave Ingamells; Rami Barghout, PE
Avid Bioservices
PAO-03-24-CL-06
March 14, 2024
Digital Pathology
Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform
Nathan Buchbinder
Proscia
PAO-01-24-CL-2
February 29, 2024
3D Printing
Exploring New Possibilities with 3D Printing of Pharmaceuticals
Thomas Kipping, Ph.D.
MilliporeSigma
PAO-02-24-CL-11
February 23, 2024
Translation
The Translational Index Score: Improving the Entire Drug Development Cycle
Jo Varshney, Ph.D., D.V.M.
PAO-02-24-CL-10
February 15, 2024
Robotic Sterile Fill-Finish
Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services
Peter Kim; Jerome Detreille; Derek Truninger
PAO-02-24-CL-03
February 14, 2024
New Packaging
Consistent Formulation, Continuous Improvement: Introducing Robust, Easier-to-Use Detergent Packaging
Michael Moussourakis
Alconox Inc.
PAO-01-24-CL-3
January 22, 2024
Cell Culture Media
Enabling Controlled End-to-End Biomanufacturing with Animal-Free Culture Media Products
Thomas Yezzi
Nu-Tek BioSciences
PAO-08-23-CL-05
November 14, 2023
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07
November 09, 2023
Biotherapeutics
Leveraging the Tenacity of Biotherapeutics Development Experience to Build a Dynamic CDMO
John R. Mosack
Tanvex CDMO
PAO-10-23-CL-05
November 07, 2023
3D Cell Culture
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.
Corning Life Sciences
PAO-09-23-CL-02
September 29, 2023
Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
Sarah Meeks, Ph.D.
MaxCyte
PAO-09-23-CL-09
September 28, 2023
Cell Therapy
Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies
Beau Webber, Ph.D.
Luminary Therapeutics
PAO-08-23-CL-04
September 05, 2023